BD began operations in Drogheda in 1964 and is the longest established medical technology multinational company supported by the Industrial Development Agency (IDA). BD opened a second plant in Dun Laoghaire in 1969. The company's two Irish plants manufacture healthcare products such as pen needles, an insulin injection system for the treatment of diabetes.
As well as manufacturing plants in Drogheda and Dun Laoghaire, BD has a trading office in Shannon, Co Clare. In recent years, it has also acquired Clearstream Technologies, continuing to operate its plant in Enniscorthy, and Bard, likewise taking over its operations in Ireland.
Financial Data
-
31st Dec 19 Source: Estimated
- €1.9 billion turnover
- 4,500 employees
-
30th Sep 18 Source: CRO
- €31.2 million turnover
-
€2.1 million
profit - 99 employees
- 10 more years available »
Ranking
By Turnover
(€1.9 billion)- 57th in Top Companies
- 11th in Health
- 9th in Pharma
By Employees
(4,500)- 52nd in Top Companies
- 10th in Health
- 5th in Pharma
-
- 4,500
- €1.9 billion
Employees
- Roland Goette CEO/Managing Director
Latest News
- 7:01am Bank of Ireland paves way for negative rates on accounts with over €1m
- 6:56am Air Corps bid for search and rescue services would result in job losses, union warns
- 6:56am FBD, ICG and Uniphar under fire over executive pay
- May 07 US jobs growth slows despite reopenings and vaccinations
- May 07 Regulator expects FBD to pay ‘all reasonable costs’ of publicans, court told